Breakthrough In Highly Lethal Childhood Cancer Could Change The Natural History of The Disease
As reported today at the American Society of Clinical Oncology (ASCO) meeting, researchers at the Nagourney Cancer Institute and Metabolomycs, California-based biotechnology companies working with the FibroFighters Foundation, combined mass spectrometry with functional profiling in Fibrolamellar cancers to identify previously unrecognized therapeutic vulnerabilities in this highly lethal childhood malignancy. The investigators showed that Fibrolamellar cancers appear to arise through changes in cellular metabolism.
